Meeting Banner
Abstract #3911

MR-Spectroscopic Imaging in the Spotlight of the 2016 WHO Classification

Elie Diamandis1, Carl Philipp Simon Gabriel2, Horst Urbach3, Irina Mader1, and Dieter Henrik Heiland4

1Department of Neuroradiology, Medical Center Freiburg, Freiburg, Germany, 2Department of Neuroradiology, Medical Center Freiburg, Freibrug, Germany, 3Department of Neuroradiology, Medical Center Freiburg, Frieburg, Germany, 4Department of Neurosurgery, Medical Center Freiburg, Freiburg, Germany

The purpose of this study is to map spatial metabolite differences across the three molecular subgroups of glial tumors, defined by the IDH1/2 mutation and 1p19q-co-deletion, using chemical shift imaging. The classification was based on a radiomic approach to the spectroscopic data.

This abstract and the presentation materials are available to members only; a login is required.

Join Here

Abstract